You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Choroidal Neovascularization
 •Macular Degeneration
 •Retinal/ Chorioretinal Disorders
 •Alert me on articles by topic

Iris Pigment Epithelial Translocation in the Treatment of Exudative Macular Degeneration

A 3-Year Follow-up

Sabine Aisenbrey, MD; Bart A. Lafaut, MD; Peter Szurman, MD; Ralph-Dieter Hilgers, PhD; Peter Esser, MD; Peter Walter, MD; Karl U. Bartz-Schmidt, MD; Gabriele Thumann, MD

Arch Ophthalmol. 2006;124:183-188.

Objective  To report the functional and anatomical outcome of 20 patients who underwent surgical removal of choroidal neovascularization combined with transplantation of autologous iris pigment epithelial cells to the subretinal space 3 years after treatment.

Methods  Freshly isolated autologous iris pigment epithelial cells were translocated to the subretinal space in 20 patients after membrane extraction. Patients were followed up by funduscopy, angiography, microperimetry, and visual acuity testing.

Results  After a follow-up of 3 years, 1 patient showed improved visual acuity, 13 patients retained stable visual acuity, and 3 patients had reduced visual acuity. No macular edema or recurrent choroidal neovascularization was apparent at any time during the follow-up.

Conclusions  Transplanted autologous iris pigment epithelial cells were well tolerated for 3 years and stabilization of visual acuity was achieved in most patients. These results suggest that iris pigment epithelial cells may serve as a substitute for retinal pigment epithelial cells after choroidal neovascularization removal in patients with exudative macular degeneration; however, whether these cells will be of any value for the restoration of vision and possible protection against choroidal neovascularization recurrence awaits further clinical observation and additional research.


Author Affiliations: Center of Ophthalmology, Department of Vitreoretinal Surgery, Eberhard-Karls University Tuebingen, Tuebingen, Germany (Drs Aisenbrey, Szurman, and Bartz-Schmidt); Department of Ophthalmology, University Hospital Ghent, Ghent, Belgium (Dr Lafaut); Department of Medical Biometry, University of Aachen, Aachen, Germany (Dr Hilgers); and University of Cologne, Center of Ophthalmology, Department of Vitreo-Retinal Surgery, Cologne, Germany (Drs Esser, Walter, and Thumann).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term Follow-up of Macular Translocation With 360{degrees} Retinotomy for Exudative Age-Related Macular Degeneration
Aisenbrey et al.
Arch Ophthalmol 2007;125:1367-1372.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.